(S)-WAY 100135, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine.

[1]  M. Carli,et al.  8-OH-DPAT impairs spatial but not visual learning in a water maze by stimulating 5-HT1A receptors in the hippocampus , 1995, Behavioural Brain Research.

[2]  J. Izumi,et al.  Hippocampal Serotonin 5‐HT1A Receptor Enhances Acetylcholine Release in Conscious Rats , 1994, Journal of neurochemistry.

[3]  E. Anderson,et al.  5-HT1A and 5-HT4 receptor colocalization on hippocampal pyramidal cells , 1994, Neuropharmacology.

[4]  C. Dourish,et al.  Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study. , 1993, European journal of pharmacology.

[5]  Y. Reilly,et al.  WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors. , 1993, European journal of pharmacology.

[6]  M. Carli,et al.  Stimulation of 5-HT1A receptors in the dorsal hippocampus impairs acquisition and performance of a spatial task in a water maze , 1992, Brain Research.

[7]  M. Carli,et al.  8‐Hydroxy‐2‐(di‐n‐propylamino)tetralin impairs spatial learning in a water maze: role of postsynaptic 5‐HT1A receptors , 1992, British journal of pharmacology.

[8]  Stephen B. Dunnett,et al.  The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions , 1991, Trends in Neurosciences.

[9]  R. Andrade,et al.  Pharmacological and functional analysis of a novel serotonin receptor in the rat hippocampus. , 1990, European journal of pharmacology.

[10]  M. Freedman,et al.  Non‐Alzheimer‐type pattern of brain cholineacetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy , 1989, Annals of neurology.

[11]  A. Colino,et al.  Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin , 1987, Nature.

[12]  G Maura,et al.  Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release. , 1986, European journal of pharmacology.

[13]  L. Squire,et al.  Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  M. Segal.  Multiple actions of acetylcholine at a muscarinic receptor studied in the rat hippocampal slice , 1982, Brain Research.

[15]  D. Prince,et al.  Acetylcholine induced modulation of hippocampal pyramidal neurons , 1981, Brain Research.

[16]  S. Snyder,et al.  Postsynaptic localization of muscarinic cholinergic receptor binding in rat hippocampus. , 1974, Brain research.

[17]  Seymour Geisser,et al.  Statistical Principles in Experimental Design , 1963 .

[18]  L. Thal,et al.  Significance of neurotransmitter abnormalities in Alzheimer's disease. , 1986, Research publications - Association for Research in Nervous and Mental Disease.

[19]  Joseph B. Martin,et al.  Neuropeptides in neurologic and psychiatric disease. , 1986, Research publications - Association for Research in Nervous and Mental Disease.